These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36550485)

  • 1. LiSA: an assisted literature search pipeline for detecting serious adverse drug events with deep learning.
    Martenot V; Masdeu V; Cupe J; Gehin F; Blanchon M; Dauriat J; Horst A; Renaudin M; Girard P; Zucker JD
    BMC Med Inform Decis Mak; 2022 Dec; 22(1):338. PubMed ID: 36550485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial intelligence-powered pharmacovigilance: A review of machine and deep learning in clinical text-based adverse drug event detection for benchmark datasets.
    Li Y; Tao W; Li Z; Sun Z; Li F; Fenton S; Xu H; Tao C
    J Biomed Inform; 2024 Apr; 152():104621. PubMed ID: 38447600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Augmented Intelligence for Pharmacovigilance Case Seriousness Determination.
    Routray R; Tetarenko N; Abu-Assal C; Mockute R; Assuncao B; Chen H; Bao S; Danysz K; Desai S; Cicirello S; Willis V; Alford SH; Krishnamurthy V; Mingle E
    Drug Saf; 2020 Jan; 43(1):57-66. PubMed ID: 31605285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep learning approaches for extracting adverse events and indications of dietary supplements from clinical text.
    Fan Y; Zhou S; Li Y; Zhang R
    J Am Med Inform Assoc; 2021 Mar; 28(3):569-577. PubMed ID: 33150942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inferring ADR causality by predicting the Naranjo Score from Clinical Notes.
    Rawat BPS; Jagannatha A; Liu F; Yu H
    AMIA Annu Symp Proc; 2020; 2020():1041-1049. PubMed ID: 33936480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of hand-foot syndrome from cancer patients' blog posts: BERT-based deep-learning approach to detect potential adverse drug reaction symptoms.
    Nishioka S; Watanabe T; Asano M; Yamamoto T; Kawakami K; Yada S; Aramaki E; Yajima H; Kizaki H; Hori S
    PLoS One; 2022; 17(5):e0267901. PubMed ID: 35507636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From narrative descriptions to MedDRA: automagically encoding adverse drug reactions.
    Combi C; Zorzi M; Pozzani G; Moretti U; Arzenton E
    J Biomed Inform; 2018 Aug; 84():184-199. PubMed ID: 29981491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Use of Artificial Intelligence in Pharmacovigilance: A Systematic Review of the Literature.
    Salas M; Petracek J; Yalamanchili P; Aimer O; Kasthuril D; Dhingra S; Junaid T; Bostic T
    Pharmaceut Med; 2022 Oct; 36(5):295-306. PubMed ID: 35904529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying the serious clinical outcomes of adverse reactions to drugs by a multi-task deep learning framework.
    Zhao H; Ni P; Zhao Q; Liang X; Ai D; Erhardt S; Wang J; Li Y; Wang J
    Commun Biol; 2023 Aug; 6(1):870. PubMed ID: 37620651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Algorithmic Identification of Treatment-Emergent Adverse Events From Clinical Notes Using Large Language Models: A Pilot Study in Inflammatory Bowel Disease.
    Silverman AL; Sushil M; Bhasuran B; Ludwig D; Buchanan J; Racz R; Parakala M; El-Kamary S; Ahima O; Belov A; Choi L; Billings M; Li Y; Habal N; Liu Q; Tiwari J; Butte AJ; Rudrapatna VA
    Clin Pharmacol Ther; 2024 Jun; 115(6):1391-1399. PubMed ID: 38459719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting adverse drug reactions in discharge summaries of electronic medical records using Readpeer.
    Tang Y; Yang J; Ang PS; Dorajoo SR; Foo B; Soh S; Tan SH; Tham MY; Ye Q; Shek L; Sung C; Tung A
    Int J Med Inform; 2019 Aug; 128():62-70. PubMed ID: 31160013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Mandatory Reporting of Non-Serious Safety Reports to EudraVigilance on the Detection of Adverse Reactions.
    Candore G; Monzon S; Slattery J; Piccolo L; Postigo R; Xurz X; Strauss S; Arlett P
    Drug Saf; 2022 Jan; 45(1):83-95. PubMed ID: 34881404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective Evaluation of Adverse Event Recognition Systems in Twitter: Results from the Web-RADR Project.
    Gattepaille LM; Hedfors Vidlin S; Bergvall T; Pierce CE; Ellenius J
    Drug Saf; 2020 Aug; 43(8):797-808. PubMed ID: 32410156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Importance of Direct Patient Reporting of Adverse Drug Reactions in the Safety Monitoring Process.
    Sienkiewicz K; Burzyńska M; Rydlewska-Liszkowska I; Sienkiewicz J; Gaszyńska E
    Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementing the US Food and Drug Administration Adverse Event Reporting System With Adverse Drug Reaction Reporting From Social Media: Comparative Analysis.
    Zhou Z; Hultgren KE
    JMIR Public Health Surveill; 2020 Sep; 6(3):e19266. PubMed ID: 32996889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse Drug Reaction Case Safety Practices in Large Biopharmaceutical Organizations from 2007 to 2017: An Industry Survey.
    Stergiopoulos S; Fehrle M; Caubel P; Tan L; Jebson L
    Pharmaceut Med; 2019 Dec; 33(6):499-510. PubMed ID: 31933240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting Database.
    Castillon G; Salvo F; Moride Y
    Drug Saf; 2019 Jan; 42(1):27-34. PubMed ID: 30121742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial Intelligence for Unstructured Healthcare Data: Application to Coding of Patient Reporting of Adverse Drug Reactions.
    Létinier L; Jouganous J; Benkebil M; Bel-Létoile A; Goehrs C; Singier A; Rouby F; Lacroix C; Miremont G; Micallef J; Salvo F; Pariente A
    Clin Pharmacol Ther; 2021 Aug; 110(2):392-400. PubMed ID: 33866552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supervised signal detection for adverse drug reactions in medication dispensing data.
    Hoang T; Liu J; Roughead E; Pratt N; Li J
    Comput Methods Programs Biomed; 2018 Jul; 161():25-38. PubMed ID: 29852965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.